Brief: Health Canada Approves Tetra Bio Pharma's Clinical Trial Protocol For Its Drug As An Alternative To Fentanyl
08/08/2018 19:23
Aug 8 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO PHARMA SAYS HEALTH CANADA APPROVED ITS PROTOCOL
FOR A
CLINICAL TRIAL INVESTIGATING ITS PPP001 DRUG AS AN ALTERNATIVE
TO THE OPIOID FENTANYL
Source text for Eikon: ID:nGNXjM8Bs
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding